Skip links

Periodontal Disease Market in the 7MM is expected to expand at a healthy growth rate by 2032, estimates DelveInsight

DelveInsight’s “Periodontal Disease Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Periodontal Disease, historical and forecasted epidemiology as well as the Periodontal Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Discover Key Insights into the Periodontal Disease Market with DelveInsight’s In-Depth Report @ Periodontal Disease Market Size

Key Takeaways from the Periodontal Disease Market Report

  • In September 2024:- Xeolas Pharmaceuticals- The purpose of the study is to determine the efficacy and safety of the effects of a topical medication on bone remodeling after dental extraction, in order to establish whether such treatment can be a new therapeutic option for said pathology. The participation of 60 patients is expected, who will be divided randomly in equal proportions into two groups. Treatment groups: Group A (30 patients): medication administered topically. Group B (30 patients): placebo with characteristics equal to the drug under investigation.
  • The Periodontal Disease market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • According to the Centers for Disease Control and Prevention (CDC), almost 50 percent of adults in the US, over the age of 30, have the advanced form of periodontal disease, or gum disease. The data confirmed that gum disease is prevalent in the United States. Americans bear a very heavy burden when it comes to periodontal disease
  • In a study by Abe et al. (2022), periodontal disease is currently the leading cause (40.4% in men and 34.9% in women), surpassing caries (30.2% in men and 29.0% in women)
  • The leading Periodontal Disease Companies such as Geistlich Pharma AG, Noveome Biotherapeutics, Amyndas Pharmaceuticals, and others
  • Promising Periodontal Disease Therapies such as PerioSept(r), ST266, AMY 101, and others

Stay ahead in the Periodontal Disease Therapeutics Market with DelveInsight’s Strategic Report @ Periodontal Disease Market Outlook

Periodontal Disease Epidemiology Segmentation

  • Total Prevalence of Periodontal Disease
  • Prevalent Cases of Periodontal Disease by severity
  • Gender-specific Prevalence of Periodontal Disease
  • Diagnosed Cases of Episodic and Chronic Periodontal Disease

Download the report to understand which factors are driving Periodontal Disease epidemiology trends @ Periodontal Disease Prevalence

Periodontal Disease Market Strengths

  • Late-stage pipeline drugs such as Faricimab, Beovu and KSI-301 are some of the potential emerging therapies that have shown promising results and expected to improve the dosing interval

Periodontal Disease Market Unmet Needs

  • Need of novel and effective treatment for periodontal disease
  • Need to develop management guidelines for adolescents and adults with periodontal disease
  • Need for reassessment of doses for periodontal disease

Get In-Depth Knowledge on Periodontal Disease Market Trends and Forecasts with DelveInsight @ Periodontal Disease Treatment Market

Periodontal Disease Therapies and Companies

  • PerioSept(r): Geistlich Pharma AG
  • ST266: Noveome Biotherapeutics
  • AMY 101: Amyndas Pharmaceuticals

Scope of the Periodontal Disease Market Report

  • Coverage- 7MM
  • Periodontal Disease Companies- Geistlich Pharma AG, Noveome Biotherapeutics, Amyndas Pharmaceuticals, and others
  • Periodontal Disease Therapies- PerioSept(r), ST266, AMY 101, and others.
  • Periodontal Disease Therapeutic Assessment: Periodontal Disease Current marketed and Periodontal Disease emerging therapies
  • Periodontal Disease Market Dynamics: Periodontal Disease market drivers and Periodontal Disease market barriers

Unlock Strategic Insights with DelveInsight’s Comprehensive Periodontal Disease Market Report @ Periodontal Disease Market Drivers and Barriers

Table of Contents

1. Periodontal Disease Market Report Introduction

2. Executive Summary for Periodontal Disease

3. SWOT analysis of Periodontal Disease

4. Periodontal Disease Patient Share (%) Overview at a Glance

5. Periodontal Disease Market Overview at a Glance

6. Periodontal Disease Disease Background and Overview

7. Periodontal Disease Epidemiology and Patient Population

8. Country-Specific Patient Population of Periodontal Disease

9. Periodontal Disease Current Treatment and Medical Practices

10. Periodontal Disease Unmet Needs

11. Periodontal Disease Emerging Therapies

12. Periodontal Disease Market Outlook

13. Country-Wise Periodontal Disease Market Analysis

14. Periodontal Disease Market Access and Reimbursement of Therapies

15. Periodontal Disease Market Drivers

16. Periodontal Disease Market Barriers

17. Periodontal Disease Appendix

18. Periodontal Disease Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/case-study/in-licensing-opportunity

Leave a comment